THE WOODLANDS, Texas, March 17 /PRNewswire/ -- eCardio Diagnostics (www.ecardio.com) announced today that the company has launched an Academic Medicine initiative to provide a tailored offering to university-based health systems. It is the first time an arrhythmia monitoring company has addressed the unique workflow, teaching and research responsibilities of academic medical centers.
"At eCardio, we work closely with physicians to develop our products and services," noted Larry Lawson, President and Chief Executive Officer. "Academic medical centers have unique needs related to their teaching and research programs that are not met by traditional monitoring services. In response to that feedback, we have developed the first offering by an arrhythmia monitoring company specifically designed to meet the demands of university-delivered care."
The eCardio Academic Medicine service offers:
To lead this initiative, the company has appointed John Elsholz as Vice President of Academic Medicine. Elsholz has worked in the area of cardiac rhythm management for more than 25 years in both academic and industrial settings. After studying atrial fibrillation in cardiovascular research at the
Most recently, Elsholz served as Vice President of Product Development at Witt Biomedical before returning to the
About eCardio Diagnostics
eCardio Diagnostics, www.ecardio.com, is the nation's leading provider of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in the ambulatory setting. eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses--contributing to the timeliest, most effective and appropriate management of cardiac patients.
|SOURCE eCardio Diagnostics|
Copyright©2009 PR Newswire.
All rights reserved